Advanced Accelerator Applications Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 600
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $3.9B
Latest Deal Amount

Advanced Accelerator Applications General Information

Description

Provider of molecular imaging and therapy for personalized medicine intended to develop predictive, preventive and personalized tools and procedures that have the potential to radically transform healthcare. The company's Theragnostics platform merges the fields of tumor diagnostics with that of therapy to try and improve upon existing techniques. Through its capabilities in disease identification, targeting, treatment and monitoring.

Contact Information

Website
www.adacap.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Therapeutic Devices
Diagnostic Equipment
Parent Company
Primary Office
  • 20 Rue Diesel
  • 01630 Saint-Genis-Pouilly
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Accelerator Applications Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 22-Jan-2018 $3.9B 00000 00.00 Completed Profitable
6. IPO 16-Nov-2015 000.00 00000 00000 Completed Clinical Trials - Phase 3
5. Later Stage VC 23-Jun-2015 000.00 00000 Completed Clinical Trials - Phase 3
4. Later Stage VC 17-Feb-2014 000.00 00000 Completed Generating Revenue
3. Later Stage VC 23-May-2013 00.000 000.00 Completed Generating Revenue
2. Later Stage VC 25-Jul-2011 $57.2M $79M Completed Generating Revenue
1. Early Stage VC $21.8M $21.8M Completed Generating Revenue
To view Advanced Accelerator Applications’s complete valuation and funding history, request access »

Advanced Accelerator Applications Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of molecular imaging and therapy for personalized medicine intended to develop predictive, preventive and perso
Pharmaceuticals
Saint-Genis-Pouilly, France
600 As of 2018
00000
0.00 0000-00-00
000000&0 00000

000000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
00000000000 0000000
Ans, Belgium
000 As of 0000
00000000000

000 (000

strud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in
000000000 00000 (0000000000)
London, United Kingdom
00 As of 0000
00.00
0000000000 00.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Advanced Accelerator Applications Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Trasis Formerly VC-backed Ans, Belgium 000 00000000000
000 (000000000 000 Venture Capital-Backed London, United Kingdom 00 00.00 0000000000 00.00
0000000 Formerly VC-backed Paris, France 00 000.00 000000&0 000.00
000000 0000000 Private Equity-Backed Oxford, United Kingdom 00 00.00 0000000000 00.00
000000 000000 Formerly VC-backed Berlin, Germany 00 00000 000000000 00000
You’re viewing 5 of 12 competitors. Get the full list »

Advanced Accelerator Applications Executive Team (15)

Name Title Board Seat Contact Info
Sidonie Golombowski-Daffne Chairman & President
Caio Kugelmas Chief Financial Officer
Giovanni Cerutti Business Unit Head, Molecular Imaging
Richard Valeix Head of International Sales & Marketing
Elzbieta Obielecka Head of Strategy
You’re viewing 5 of 15 executive team members. Get the full list »

Advanced Accelerator Applications Board Members (14)

Name Representing Role Since
Andrea Ruben Levi Self Board Member 000 0000
Christian Merle Self Independent Director 000 0000
Claudio Costamagna Self Chairman 000 0000
Eugenio Aringhieri Self Board Member 000 0000
Kapil Dhingra MD Self Independent Director 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Advanced Accelerator Applications Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced Accelerator Applications Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adage Capital Management Hedge Fund Minority 000 0000 000000 0
Carpefin Other Minority 000 0000 000000 0
Dompé Corporation Minority 000 0000 000000 0
Expansinvest PE/Buyout Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Advanced Accelerator Applications Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0-00 0000000000000 26-May-2016 000000000 00000 00 Buildings and Property 0é0000 000 00.0
000 0000000 07-Jan-2016 000000000000000000 Biotechnology 0000000 00000
000000 00000000000 05-Jan-2015 000000000 000.00 Biotechnology 0000000 00000
00000 0000000 01-Dec-2014 000000000 00.00 Biotechnology
GE Healthcare (FDG-PET Radiopharmaceutical Business) 11-Sep-2014 Merger/Acquisition Other Healthcare Technology Systems 0000000 00000
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

Advanced Accelerator Applications Subsidiaries (5)

Company Name Industry Location Founded
Umbra Medical Biotechnology Cologne, Germany 2008
00000000 Pharmaceuticals Saluggia, Italy 0000
0000000 000000000 Distributors (Healthcare) Chilcompton, United Kingdom 0000
00000000000 Biotechnology Saint Louis, MO 0000
000 0000000 Biotechnology Baarle-Nassau, Netherlands
To view Advanced Accelerator Applications’s complete subsidiaries history, request access »